ArticleMolecular medicine reports2018

A novel method to detect the Mexican founder mutation BRCA1 ex9‑12del associated with breast and ovarian cancer using quantitative polymerase chain reaction and TaqMan® probes.

Denisse Aideé Martínez-Treviño et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.